Arcadia Biosciences Stock - Sunday background on the small-cap agtech player

Arcadia Biosciences is a thinly traded agtech small cap on Nasdaq. With no fresh corporate news over the weekend, Sunday is a good moment to recap the company's background, business focus and recent trading context for long-term oriented retail investors.

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 13:28 UTC. Details in the imprint.

Arcadia Biosciences (US03020Q1058) is a small-cap agricultural biotechnology stock on Nasdaq. With no new filings or press releases over the weekend, this Sunday update focuses on the company’s background, management history and trading context.

What recent data show

Arcadia Biosciences has not published a new investor relations release, SEC filing or major transaction update over the last few days based on a review of its IR site and public filings.

The most recent readily accessible quote information shows the stock last closed at $0.78 on Nasdaq, implying a market capitalization close to $1.1 million at that price level. Recent technical data from TradingKey list a closing price of $0.777 on 06/18/2026 and a market cap of about $1.07 million.

Sunday focus on background

With no fresh hook such as an earnings release, analyst rating change or regulatory filing, Sunday is a sensible moment to look at the company’s origins, strategy shifts and the governance framework around this micro-cap stock.

Arcadia was founded in 2002 and has cycled through several strategic reorientations, including work on trait technologies for crops and a later pivot toward consumer-facing health and wellness ingredients. Historical company materials highlight collaborations with major agribusiness and food brands over the years. The company’s website outlines this evolution in broad strokes.

The product behind the stock

Arcadia Biosciences focuses on plant-based health and nutrition ingredients, such as reduced-gluten wheat and other value-added grain traits, which it has sought to monetize via seed sales, licensing and branded consumer products rather than traditional bulk commodity channels.

Where the stock trades today

The shares of Arcadia Biosciences (US03020Q1058) most recently traded on Nasdaq at $0.78 as of 06/18/2026, 16:00 ET.

Key facts on Arcadia Biosciences stock

• Company: Arcadia Biosciences Inc.
• ISIN: US03020Q1058
• Ticker: RKDA
• Venue: Nasdaq
• Price (as of 06/18/2026, 16:00 ET): 0.78 USD
• Market cap: 1.1 million USD (as of 06/18/2026)
• Sector / Industry: Consumer Staples / Agricultural Products & Ingredients
• Index membership: not a member of major benchmark indices such as the S&P 500 or Nasdaq-100
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.